Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
2.56
Dec. 13, 2024 16:00:01- Change 0.16 (6.6667%)
- Volume 100,573
- Today's Open 2.36
- Previous Close 2.4
- Today's High 2.5711
- Today's Low 2.36
- 52 Week High 3.43
- 52 Week Low 1.57